TNON
Tenon Medical, Inc.
NasdaqCMUSDEQUITY
Healthcare
DELAYED
Sell
-34/100
Last price
3.73
▲ 0.03 (0.81%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
3.83
Prev close
3.70
Day high
3.82
Day low
3.62
Volume
426.89K
Market cap
$9.99M
P/E (TTM)
—
52W range
2.40 – 50.40
Day trading desk
Gap from prior close
+3.51%
Prior close 3.70
VWAP
3.74
-0.38% from price
Relative volume
0.10×
Quiet session
Session range
7.18%
3.62 – 3.88
Position in range
42%
Mid range
ATR (14D)
0.49
13.20% of price
Prior day high
3.82
PDH
Prior day low
3.52
PDL
Bid / ask spread
—
Quote not published
Session volume
672.32K
Avg 6.49M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+36.08%
+34.1%
1M
-0.13%
-1.3%
3M
-53.85%
-58.4%
6M
-85.87%
-104.1%
YTD
-88.85%
-103.1%
1Y
-91.37%
-107.8%
3Y
-99.14%
-181.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on TNON open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+1.55M
Net buying
Buy transactions
42
1.78M shares
Sell transactions
7
229.38K shares
Net transactions
+49
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
39.05K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 10, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 108.14K | $455.56K | Direct |
| Sep 10, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 125.92K | $520.44K | Direct |
| Sep 8, 26 | WILLIAMSON KEVIN Chief Financial Officer |
— | 30 | — | Direct |
| Sep 4, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 1.51K | $5.57K | Direct |
| Sep 3, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 1.66K | $6.60K | Direct |
| Sep 2, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 450 | $2.04K | Direct |
| Sep 1, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 1.79K | $8.18K | Direct |
| Aug 31, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 8.30K | $41.06K | Direct |
| Aug 28, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
BUY | 18.36K | $94.38K | Direct |
| Aug 27, 26 | HRT FINANCIAL L.P Beneficial Owner of more than 10% of a Class of Security |
SELL | 419 | $2.08K | Direct |
| Jul 31, 26 | FERRARI RICHARD M Director |
— | 64.48K | — | Direct |
| Jul 31, 26 | WEIGLE ROBERT K. Director |
— | 10.73K | — | Direct |
| Jul 31, 26 | HOCHSCHULER STEPHEN H Director |
— | 10.73K | — | Direct |
| Jul 31, 26 | FOSTER STEVEN M Chief Executive Officer |
— | 140.94K | — | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
FERRARI RICHARD M |
Director | 135.24K | Conversion of Exercise of derivative security |
FOSTER STEVEN M |
Chief Executive Officer | 262.96K | Conversion of Exercise of derivative security |
GEIST WYATT D. |
Officer | — | Stock Award(Grant) |
GINN RICHARD |
Chief Technology Officer | 167.36K | Conversion of Exercise of derivative security |
GRAWEY NATHANIEL A. |
Officer | — | Stock Award(Grant) |
HOCHSCHULER STEPHEN H |
Director | 18.67K | Conversion of Exercise of derivative security |
HOWARD IVAN |
Director | 19.19K | Conversion of Exercise of derivative security |
HRT FINANCIAL L.P |
Beneficial Owner of more than 10% of a Class of Security | 18.49K | Purchase |
JACQUES KRISTINE M |
Director | 20.88K | Conversion of Exercise of derivative security |
WEIGLE ROBERT K. |
Director | 18.28K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$9.99M
Enterprise value$9.55M
Revenue (TTM)$5.31M
Gross profit$3.55M
EBITDA$-11.80M
Net income$-13.70M
EPS (TTM)$-44.86
Free cash flow$-6.12M
Total cash$1.68M
Total debt$5.68M
Book value / share$-14.57
Shares outstanding2.69M
Float620.83K
Short % of float34.46%
Dividend yield0.00%
Beta (5Y)1.36
Valuation & profitability ratios
Trailing P/E—
Forward P/E-0.31
PEG ratio—
Price / sales—
Price / book—
EV / revenue1.80
EV / EBITDA-0.81
Gross margin66.81%
Operating margin-262.24%
Profit margin-257.85%
Return on equity-551.19%
Return on assets-71.98%
Debt / equity—
Current ratio0.58
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.94M | $3.28M | $2.93M | $691.00K | +20.4% |
| Operating revenue | $3.94M | $3.28M | $2.93M | $691.00K | +20.4% |
| Cost of revenue | $1.59M | $1.57M | $1.69M | $1.33M | +1.3% |
| Gross profit | $2.36M | $1.71M | $1.24M | -$641.00K | +37.8% |
| Research & development | $2.15M | $2.60M | $3.16M | $2.83M | -17.4% |
| Selling, general & admin | $13.00M | $12.87M | $13.80M | $15.26M | +1.0% |
| Total operating expense | $15.15M | $15.48M | $16.97M | $18.08M | -2.1% |
| Operating income | -$12.79M | -$13.77M | -$15.73M | -$18.73M | +7.1% |
| Net interest income | $0 | -$34.00K | -$21.00K | -$354.00K | +100.0% |
| Pre-tax income | -$12.56M | -$13.67M | -$15.58M | -$18.92M | +8.2% |
| Net income | -$12.56M | -$13.67M | -$15.58M | -$18.92M | +8.2% |
| Net income to common | -$12.56M | -$13.67M | -$15.58M | -$18.92M | +8.2% |
| Basic EPS | -59.50 | -394.10 | -2,405.20 | -6,613.60 | +84.9% |
| Diluted EPS | -59.50 | -394.10 | -2,405.20 | -6,613.60 | +84.9% |
| EBIT | -$12.56M | -$13.64M | -$15.56M | -$18.56M | +7.9% |
| EBITDA | -$12.03M | -$12.98M | -$15.13M | -$18.27M | +7.4% |
| Basic shares | 210.97K | 34.69K | 6.48K | 2.86K | +508.2% |
| Diluted shares | 210.97K | 34.69K | 6.48K | 2.86K | +508.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.76M | $6.54M | $2.43M | $2.13M | — | -42.5% |
| Cash & short-term investments | $3.76M | $6.54M | $2.43M | $8.57M | — | -42.5% |
| Accounts receivable | $1.70M | $863.00K | $518.00K | $228.00K | — | +96.8% |
| Inventory | $1.05M | $606.00K | $554.00K | $415.00K | — | +73.9% |
| Total current assets | $6.77M | $8.21M | $3.89M | $9.35M | — | -17.6% |
| Property, plant & equipment | $1.05M | $1.15M | $1.61M | $1.67M | — | -8.9% |
| Goodwill & intangibles | $2.89M | $0 | — | — | — | — |
| Total assets | $10.76M | $9.84M | $6.34M | $11.09M | — | +9.3% |
| Total current liabilities | $3.21M | $1.87M | $3.14M | $2.53M | — | +71.9% |
| Current debt | — | — | $1.17M | — | $13.51M | — |
| Total debt | $141.00K | $428.00K | $1.86M | $911.00K | — | -67.1% |
| Total liabilities | $5.72M | $3.87M | $5.57M | $4.84M | — | +47.7% |
| Retained earnings | -$81.30M | -$68.75M | -$55.07M | -$39.49M | — | -18.3% |
| Shareholder equity | $5.04M | $5.97M | $778.00K | $6.25M | — | -15.6% |
| Working capital | $3.56M | $6.34M | $749.00K | $6.82M | — | -43.9% |
| Net tangible assets | $2.15M | $5.97M | $778.00K | $6.25M | — | -64.0% |
| Shares issued | 310.04K | 89.68K | 9.29K | 4.01K | — | +245.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$12.56M | -$13.67M | -$15.58M | -$18.92M | +8.2% |
| Depreciation & amortisation | $530.00K | $655.00K | $426.00K | $289.00K | -19.1% |
| Stock-based compensation | $1.69M | $3.85M | $4.14M | $2.90M | -56.0% |
| Change in working capital | -$426.00K | -$746.00K | -$1.17M | $1.72M | +42.9% |
| Operating cash flow | -$10.74M | -$9.88M | -$12.18M | -$12.03M | -8.8% |
| Capital expenditure | -$273.00K | -$186.00K | -$361.00K | -$847.00K | -46.8% |
| Investing cash flow | -$1.02M | -$186.00K | $6.14M | -$2.88M | -450.0% |
| Financing cash flow | $8.99M | $14.13M | $6.30M | $14.11M | -36.4% |
| Free cash flow | -$11.02M | -$10.06M | -$12.54M | -$12.87M | -9.5% |
| End cash position | $3.76M | $6.54M | $2.43M | $2.13M | -42.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $1.28M | $1.38M | $1.48M | $1.17M | $564.00K | — | -7.3% |
| Operating revenue | $1.28M | $1.38M | $1.48M | $1.17M | $564.00K | — | -7.3% |
| Cost of revenue | $465.00K | $434.00K | $464.00K | $400.00K | $319.00K | — | +7.1% |
| Gross profit | $814.00K | $945.00K | $1.02M | $773.00K | $245.00K | — | -13.9% |
| Research & development | $768.00K | $662.00K | $527.00K | $428.00K | $503.00K | — | +16.0% |
| Selling, general & admin | $3.40M | $3.56M | $3.36M | $3.74M | $2.60M | — | -4.6% |
| Total operating expense | $4.17M | $4.22M | $3.88M | $4.17M | $3.10M | — | -1.3% |
| Operating income | -$3.35M | -$3.28M | -$2.87M | -$3.39M | -$2.86M | — | -2.3% |
| Net interest income | -$852.00K | -$176.00K | $0 | $0 | $0 | — | -384.1% |
| Pre-tax income | -$4.05M | -$3.48M | -$2.83M | -$3.34M | -$2.77M | — | -16.5% |
| Net income | -$4.05M | -$3.48M | -$2.83M | -$3.34M | -$2.77M | — | -16.5% |
| Net income to common | -$4.05M | -$3.48M | -$2.83M | -$3.34M | -$2.77M | — | -16.5% |
| Basic EPS | -12.35 | -10.85 | — | -14.00 | -12.76 | -35.35 | -13.8% |
| Diluted EPS | -12.35 | -10.85 | — | -14.00 | -12.76 | -35.35 | -13.8% |
| EBIT | -$3.20M | -$3.30M | -$2.83M | -$3.34M | -$2.77M | — | +3.1% |
| EBITDA | -$3.07M | -$3.15M | -$2.67M | -$3.19M | -$2.65M | — | +2.4% |
| Basic shares | 328.00K | 321.94K | — | 235.71K | 217.00K | 102.77K | +1.9% |
| Diluted shares | 328.00K | 321.94K | — | 235.71K | 217.00K | 102.77K | +1.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.68M | $4.61M | $3.76M | $3.44M | $7.85M | -63.6% |
| Cash & short-term investments | $1.68M | $4.61M | $3.76M | $3.44M | $7.85M | -63.6% |
| Accounts receivable | $1.95M | $1.97M | $1.70M | $1.31M | $770.00K | -1.1% |
| Inventory | $783.00K | $806.00K | $1.05M | $1.36M | $688.00K | -2.9% |
| Total current assets | $4.81M | $7.62M | $6.77M | $6.54M | $9.88M | -36.9% |
| Property, plant & equipment | $2.20M | $2.29M | $1.05M | $863.00K | $1.11M | -3.8% |
| Goodwill & intangibles | $2.86M | $2.88M | $2.89M | $2.91M | — | -0.5% |
| Total assets | $9.92M | $12.84M | $10.76M | $10.37M | $11.11M | -22.7% |
| Total current liabilities | $8.30M | $7.41M | $3.21M | $3.04M | $2.56M | +12.2% |
| Current debt | $4.33M | $3.48M | — | — | — | +24.5% |
| Total debt | $5.68M | $4.88M | $141.00K | $216.00K | $290.00K | +16.4% |
| Total liabilities | $11.66M | $10.94M | $5.72M | $5.57M | $4.40M | +6.6% |
| Retained earnings | -$88.83M | -$84.78M | -$81.30M | -$78.47M | -$75.13M | -4.8% |
| Shareholder equity | -$1.74M | $1.90M | $5.04M | $4.80M | $6.71M | -192.0% |
| Working capital | -$3.50M | $215.00K | $3.56M | $3.50M | $7.32M | -1,727.0% |
| Net tangible assets | -$4.61M | -$982.00K | $2.15M | $1.89M | $6.71M | -368.9% |
| Shares issued | 496.46K | 322.75K | 310.04K | 245.87K | 216.92K | +53.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$4.05M | -$3.48M | -$2.83M | -$3.34M | -$2.77M | -16.5% |
| Depreciation & amortisation | $128.00K | $153.00K | $164.00K | $145.00K | $114.00K | -16.3% |
| Stock-based compensation | $412.00K | $331.00K | $344.00K | $58.00K | $417.00K | +24.5% |
| Change in working capital | $38.00K | -$200.00K | $84.00K | -$688.00K | $24.00K | +119.0% |
| Operating cash flow | -$2.76M | -$2.96M | -$2.22M | -$3.82M | -$2.21M | +6.8% |
| Capital expenditure | -$172.00K | -$56.00K | -$192.00K | — | — | -207.1% |
| Investing cash flow | -$172.00K | -$56.00K | -$192.00K | -$639.00K | -$192.00K | -207.1% |
| Financing cash flow | $0 | $3.87M | $2.73M | $59.00K | -$59.00K | -100.0% |
| Free cash flow | -$2.93M | -$3.02M | -$2.42M | -$3.71M | -$2.41M | +2.9% |
| End cash position | $1.68M | $4.61M | $3.76M | $3.44M | $7.85M | -63.6% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -8.40 | -12.35 | -47.0% |
| Mar 2026 | -10.68 | -10.85 | -1.6% |
| Dec 2025 | -12.60 | -7.70 | +38.9% |
| Sep 2025 | -12.95 | -14.00 | -8.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -5.62 | 1 | $1.43M | +22.0% |
| Next quarter | -2.40 | 1 | $1.70M | +13.5% |
| Current year | -21.25 | 1 | $5.79M | +46.9% |
| Next year | -12.02 | 2 | $9.50M | +64.0% |
Analyst targets & ownership
Mean target$44.38
High target$78.75
Low target$10.00
Implied upside1089.68%
Analyst count2
ConsensusNONE
Strong buy / Buy1 / 1
Hold0
Sell / Strong sell0 / 0
Held by insiders5.85%
Held by institutions4.48%
Institutions holding17
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
3.42
+9.08% from price
SMA 20
3.89
-4.54% from price
SMA 50
5.04
-26.23% from price
SMA 100
10.71
-65.19% from price
SMA 200
20.04
-81.46% from price
EMA 12
3.69
+1.12% from price
EMA 26
4.17
-10.60% from price
EMA 50
5.81
-35.81% from price
RSI (14)
45.7
Neutral
MACD (12,26,9)
-0.48
Hist 0.14
ATR (14)
0.49
13.25% of price
Realised vol 30D
300.5%
Annualised
Bollinger upper
5.75
20, 2σ
Bollinger lower
2.04
20, 2σ
50 / 200 cross
Death
5.04 vs 20.04
Trend bias
Below 200
-81.46%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.69
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
300.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-94.6%
Peak to trough
Max drawdown 5Y
-100.0%
Peak to trough
ATR 14
0.49
13.25% of price
Beta (reported)
1.36
5Y monthly, from filing
Short interest
Shares short
539.31K
Prior 8.04K
Change vs prior
+6,606.1%
Shorts adding
% of float
34.46%
Heavily shorted
% of shares out
33.61%
Against total outstanding
Days to cover
0.0
Liquid
Float
620.83K
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 9, 25 | Alliance Global Partners | INITIATED | — | Buy |
| Nov 15, 24 | Maxim Group | MAINTAINED | Buy | Buy |
| Aug 14, 24 | Benchmark | MAINTAINED | Speculative Buy | Speculative Buy |
| Apr 15, 24 | Benchmark | MAINTAINED | Speculative Buy | Speculative Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:35
Split dateAug 10, 2026
SEC filings
Offering Registrations
S-3 · 2026-10-05
Additional Forms
D · 2026-09-21
Corporate Changes & Voting Matters
8-K · 2026-09-16
Corporate Changes & Voting Matters
8-K · 2026-09-09
Additional Forms
D · 2026-09-04
Offering Registrations
S-3/A · 2026-09-02
Corporate Changes & Voting Matters
8-K · 2026-08-31
Corporate Changes & Voting Matters
8-K/A · 2026-08-26
Headlines
BC-Most Active Stocks
Associated Press · 7d ago
Tenon(R) Medical Announces Full Commercial Launch of the SImmetry(R)+ SI Joint Fusion 3D Printed Lateral Screw Following Successful Alpha Launch
ACCESS Newswire · 7d ago
WallachBeth Capital Announces Closing of Tenon Medical Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338
PR Newswire · 23d ago
Tenon Medical Announces Closing of Warrant Inducement Offering for Aggregate Gross Proceeds of Approximately $2,872,338
ACCESS Newswire · 23d ago
WallachBeth Capital Announces Tenon Medical Warrant Inducement for Gross Proceeds of Approximately $2,872,338
PR Newswire · 25d ago
Tenon Medical Announces Warrant Inducement for Aggregate Gross Proceeds of Approximately $2,872,338
ACCESS Newswire · 26d ago
BC-Most Active Stocks
Associated Press · 26d ago
BC-Most Active Stocks
Associated Press · 27d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.